CDH1 and breast carcinoma: The aberrant expression of E-cadherin detected within the tumorsphere-derived tumors [25], as well as within the DTC-derived tumors and their metastatic lesions in the lung and liver (as presented in this study), provides initial evidence of nuclear E-cadherin in primary breast cancer cells associated with metastasis and other cellular processes.